Purchases and Sales Made in Q4 2022 in Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN) during Q4 2022. The information is specifically focused on institutions that hold shares of NeuroSense Therapeutics Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
2.24K+ 122.5% |
$2.73K - $4.25K
|
4.07K
$4.43K
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Personalized Indexing Management, LLC
Oakland, CA |
SELL
|
- |
-5.34K- 32.3% |
$6.51K - $10.1K
|
11.2K
$12.2K
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-35.9K- 66.05% |
$43.8K - $68.1K
|
18.4K
$20.1K
|